Any list of the world’s most inhumane healthcare bureaucracies has to include Britain’s National Institute for Health and Care Excellence at the top. For over two decades, the agency has employed ruthless cost-benefit analyses to effectively deny British patients access to the latest medicines.

Now NICE is looking to export its expertise rationing life-saving drugs to the United States.

The body recently announced a collaboration with the Institute for Clinical and Economic Review, a U.S. group that purports to determine the cost-effectiveness of medical treatments. Similar organizations in the Netherlands and Canada will be part of the group, too.

Click to read the full article in Newsmax.

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Scroll to Top